How Are Canadian Patients Using Medical Cannabis? | Leafly
Thursday, Sep 7, 2017

This article is sponsored by Tilray, one of the largest and most sophisticated producers of medical cannabis in the world. Tilray is dedicated to providing safe, consistent, and reliable products to patients and furthering clinical and observational research examining the therapeutic potential of cannabis.

It seems like every day brings a new study about the ways medical cannabis can be used in healthcare. But how are patients already accessing medical cannabis, and in what form? And more importantly, how is it impacting their quality of life? A new study led by Philippe Lucas, Vice-President of Patient Research & Access for Tilray, and Leafly’s own Nick Jikomes, PhD, provides some of the first answers to these questions.

Tilray ’ s Philippe Lucas presents data from the company ’ s latest patient research. (Courtesy of Tilray)

The Tilray Patient Survey 2017 saw the company partner with academics and researchers from the Cleveland Clinic, McMaster University, the University of British Columbia, and the University of Victoria on the largest survey of Canadian medical cannabis patients ever conducted, tracking the responses of 2,032 patients across Canada.

How Canadian Licensed Producers Are Driving Medical Marijuana Research Tilray cannabis oil capsules. (Courtesy of Tilray) It’s Time to Treat Medical Cannabis Like Medicine A package of medicinal flower. (Courtesy of Tilray) The Different Ways to Smoke and Consume Cannabis Cannabis may already be playing a harm-reduction role in the current opioid crisis. Philippe Lucas, Vice-President of Patient Research & Access, Tilray